Anant Labs

Tofacitinib Impurity C (Citrate)

Impureza

Esta molécula é um impureza de Tofacitinib.

Tofacitinib Impurity C (Citrate)
Em Estoque

Impureza

Tofacitinib Impurity C (Citrate)

Cat. No. ANTPRD8838CAS 2174011-55-1Em EstoqueSintetizado
WhatsAppBaixar MSDS
Dados Técnicos
Cat. No.ANTPRD8838
CAS2174011-55-1
Rel. CAS1092578-47-6 (free base)
Fórmula Mol.C22H28N6O8
Peso Mol.504.5 g/mol
IUPAC2-hydroxypropane-1,2,3-tricarboxylic acid;3-[(3S,4S)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile
SMILESC[C@H]1CCN(C(=O)CC#N)C[C@H]1N(C)c1ncnc2[nH]ccc12.O=C(O)CC(O)(CC(=O)O)C(=O)O
InChIInChI=1S/C16H20N6O.C6H8O7/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16;7-3(8)1-6(13,5(11)12)2-4(9)10/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20);13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/t11-,13+;/m0./s1
Chave InChISYIKUFDOYJFGBQ-STEACBGWSA-N
Descrição

Visão geral

Tofacitinib Impurity C (Citrate), Tofacitinib, 2174011-55-1, 2-hydroxypropane-1,2,3-tricarboxylic acid;3-[(3S,4S)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile

A Anant Labs é a renomada e autêntica fabricante e fornecedora de Tofacitinib Impurity C (Citrate) na Índia.

A Anant tem expertise em química orgânica sintética e análise farmacêutica e fornece serviços de pesquisa personalizados com custo acessível e precisão para a indústria.

Sinônimos

(3S,4S)-Tofacitinib Citrate2-hydroxypropane-1,2,3-tricarboxylicacid;3-[(3S,4S)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanenitrile3-((3S,4S)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate(3S,4S)-TOFACITINIB MONOCITRATETofacitinib citrate, (3S,4S)-GLXC-252541-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-beta-oxo-, (3S,4S)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)2-hydroxypropane-1,2,3-tricarboxylic acid; 3-[(3S,4S)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanenitrile2-hydroxypropane-1,2,3-tricarboxylic acid;3-[(3S,4S)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile3-((3S,4S)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile2-hydroxypropane-1,2,3-tricarboxylate